Methods for treating neuropsychiatric conditions
OwnerBenedikt Vollrath, Jay Lichterinventors
Life of this patent
Estimating the term…
Abstract
Provided herein are methods for treating a subject suffering from a neuropsychiatric condition (e.g., schizophrenia). The methods include systemic administration of a pharmacological composition containing a therapeutically effective amount of a PAK activator.
Claims18
A method for treating a subject suffering from a neuropsychiatric condition, comprising administering to the subject a pharmacological composition comprising a therapeutically effective amount of at least one activator of a p21-activated kinase, wherein the neuropsychiatric condition is associated with abnormal dendritic spine density, abnormal dendritic spine size, abnormal dendritic spine plasticity, abnormal dendritic spine morphology or abnormal dendritic spine motility.
(canceled)
(canceled)
(canceled)
(canceled)
-25. (canceled)
Dependencies are inferred from the claim text.